Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis C virus infection.


Journal

Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672

Informations de publication

Date de publication:
02 2019
Historique:
received: 22 06 2018
revised: 01 09 2018
accepted: 23 09 2018
pubmed: 20 10 2018
medline: 27 6 2020
entrez: 20 10 2018
Statut: ppublish

Résumé

Cirrhosis is associated with hormonal dysregulation, as evidenced by secondary amenorrhoea in reproductive-aged women, and feminization of cirrhotic men. Whether hormone levels vary by severity of cirrhosis in women is not known. If identified, such changes may have important clinical relevance, particularly, as low sex hormone binding globulin (SHBG) and follicle stimulating hormone (FSH) are known to promote metabolic and cardiovascular disease in women. In a cohort of post-menopausal women with chronic hepatitis C virus (HCV) infection, we compared comprehensive sex hormone levels by presence of cirrhosis, as well as across Child-Turcotte-Pugh (CTP) class. Results: There were n = 18 cirrhotic and n = 21 noncirrhotic women with a median age of 57 years (interquartile range [IQR] 53-62). Compared to noncirrhotics, cirrhotic women had higher oestradiol (11.0 vs 6.0 pg/mL, P = 0.05) and oestrone levels (32.0 vs 8.0 ng/mL, P < 0.001), and lower sex hormone binding globulin (SHBG) (69.2 vs 155.6 nmol/L, P = 0.001), and FSH levels (4.9 vs 89.6 mIU/mL, P < 0.001). Among cirrhotic women, there was a progressive decline in FSH and SHBG and concurrent rise in oestrone levels from CTP class A to C (test of trend, P values ≤0.02). Cirrhosis is associated with lower FSH and SHBG levels in cirrhotic compared to noncirrhotic women with HCV infection. In cirrhotic women, these levels demonstrate steady decline by disease severity. Given known associations of low SHBG and FSH with cardio-metabolic disease, the clinical implications of hormonal changes by cirrhosis severity in HCV-infected women warrants investigation.

Identifiants

pubmed: 30339729
doi: 10.1111/jvh.13027
pmc: PMC6345586
mid: NIHMS993964
doi:

Substances chimiques

Estrogens 0
Sex Hormone-Binding Globulin 0
Estradiol 4TI98Z838E
Follicle Stimulating Hormone 9002-68-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

258-262

Subventions

Organisme : NIDDK NIH HHS
ID : L30 DK089607
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK026743
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK111944
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK090209
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000004
Pays : United States

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Références

Eur J Gastroenterol Hepatol. 2018 Jan;30(1):118-120
pubmed: 29194187
Clin Gastroenterol Hepatol. 2015 Sep;13(9):1686-93.e2
pubmed: 25592661
J Hepatol. 1993 Apr;18(1):101-5
pubmed: 8340601
J Clin Endocrinol Metab. 1975 Jun;40(6):1018-26
pubmed: 1133151
Int J Epidemiol. 2015 Apr;44(2):623-37
pubmed: 26050255
J Am Heart Assoc. 2017 Aug 30;6(9):
pubmed: 28855169
Clin Liver Dis. 2017 May;21(2):321-335
pubmed: 28364816
Endocrinology. 2016 Jan;157(1):70-6
pubmed: 26496022
Hum Reprod. 2004 Jan;19(1):41-7
pubmed: 14688154
J Hepatol. 1988 Apr;6(2):258-62
pubmed: 3045196
Diabetes. 2005 Mar;54(3):765-9
pubmed: 15734854
PLoS One. 2015 Aug 04;10(8):e0134986
pubmed: 26241313
J Endocrinol Invest. 2013 Sep;36(8):588-92
pubmed: 23448998
Major Probl Clin Surg. 1964;1:1-85
pubmed: 4950264
Gastroenterol Jpn. 1991 Aug;26(4):435-9
pubmed: 1916151
Hepatology. 2008 Feb;47(2):484-92
pubmed: 18220286
N Engl J Med. 2009 Sep 17;361(12):1152-63
pubmed: 19657112
Eur J Endocrinol. 1995 Apr;132(4):444-9
pubmed: 7711882
J Endocrinol Invest. 2008 May;31(5):470-8
pubmed: 18560267
Atherosclerosis. 2004 Aug;175(2):353-9
pubmed: 15262192
Ann Hepatol. 2017 Oct 16;16(6):932-940
pubmed: 29055928
Am J Transplant. 2010 Jun;10(6):1420-7
pubmed: 20486907
Acta Diabetol. 2016 Apr;53(2):227-36
pubmed: 25959422
J Gastroenterol Hepatol. 2016 Jun;31(6):1196-202
pubmed: 26678239
Transplant Proc. 2009 Jun;41(5):1735-9
pubmed: 19545718
Endocrinology. 2017 Mar 1;158(3):545-559
pubmed: 28359088
Metabolism. 1973 May;22(5):695-701
pubmed: 4704715

Auteurs

Monika Sarkar (M)

Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, San Francisco, California.

Jennifer C Lai (JC)

Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, San Francisco, California.

Deirdre Sawinski (D)

Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Toni E Zeigler (TE)

National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin.

Marcelle Cedars (M)

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of California, San Francisco, San Francisco, California.

Kimberly A Forde (KA)

Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH